TVM Life Science Ventures VII (GP) Ltd.

https://www.tvm-lifescience.com

TVM Capital Life Science is providing venture capital to the international pharmaceutical, biopharmaceutical and medical technology industries with more than 25-years of transatlantic investment track record and in excess of US$1.1bn under management. The Life Science Investment Group's mission is to invest in the development of exciting early stage drug candidates and companies in the medical field that are or aspire to be innovative leaders in their market segment. Since 1984, TVM Capital Life Science made 117 investments in life science companies in Europe and the United States and exited from 87 companies, including 42 initial public offerings on the NASDAQ, and the London, Frankfurt, Zurich and Vienna Stock Exchanges and 25 trade sales and mergers. The Life Science team combines long-standing international investment and company building experience with their track record of dedicated board work, extensive global networks in the world of life science research and product development and a direct knowledge of the local markets. TVM Capital Life Science currently invests from its 7th fund generation, TVM Life Science Ventures VII, with an integrated team of investment professionals based in Montreal and Munich. *

	Start	2013-08-06 existent
	Group	TVM (Group)
	Industry	venture capital
	Industry 2	LIFE SCIENCES

	Region	United Kingdom (town unspecified)
	Country	United Kingdom (GB)
	Street	11–15 Seaton Place
	City	JE4 0QH St. Heller
	Tel	+49-89-998992-0
		Address record changed: 2020-12-02

Basic data	Employees	n. a.

		* Document for »About Section«:

		Record changed: 2017-04-01